COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
Authors:
- David EmesDEDavid Emes
- Anke HülsAHAnke Hüls
- Nicole BaumerNBNicole Baumer
- Mara DierssenMDMara Dierssen
- Shiela PuriSPShiela Puri
- Lauren RussellLRLauren Russell
- Stephanie L. ShermanSSStephanie L. Sherman
- Andre StrydomASAndre Strydom
- Stefania BargagnaSBStefania Bargagna
- Ana Cláudia BrandãoABAna Cláudia Brandão
- Alberto C. S. CostaAlberto C. S. Costa
- Patrick T. FeanyPFPatrick T. Feany
Open Access
- 31 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5125
Abstract
Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) than the general population, but evidence is required to understand the risks for children with DS, which is necessary to inform COVID-19 shielding advice and vaccination priorities. We aimed to determine the epidemiological and clinical characteristics of COVID-19 in children with DS. Using data from an international survey obtained from a range of countries and control data from the United States, we compared the prevalence of symptoms and medical complications and risk factors for severe outcomes between DS and non-DS paediatric populations with COVID-19. Hospitalised COVID-19 patients <18 years with DS had a higher incidence of respiratory symptoms, fever, and several medical complications from COVID-19 than control patients without DS <18 years. Older age, obesity, and epilepsy were significant risk factors for hospitalisation among paediatric COVID-19 patients with DS, and age and thyroid disorder were significant risk factors for acute respiratory distress syndrome. Mortality rates were low in all paediatric COVID-19 patients (with and without DS), contrasting with previous findings in adults with DS (who exhibit higher mortality than those without DS). Children with DS are at increased risk for more severe presentations of COVID-19. Efforts should be made to ensure the comprehensive and early detection of COVID-19 in this population and to identify children with DS who present comorbidities that pose a risk for a severe course of COVID-19. Our results emphasize the importance of vaccinating children with DS as soon as they become eligible.Keywords
All Related Versions
Funding Information
- Down Syndrome Affilicates in Action (/)
- Down Syndrome Medical Interest Group - USA (/)
- GiGi’s Playhouse (/)
- Fondation Jérôme Lejeune (/)
- LuMind IDSC Foundation (/)
- The Matthew Foundation (/)
- National Down Syndrome Society (/)
- National Task Group on Intellectual Disabilities and Dementia Practices (/)
This publication has 25 references indexed in Scilit:
- Keeping people with epilepsy safe during the COVID-19 pandemicNeurology, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?Journal of Medical Virology, 2017
- Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblingsVaccine, 2015
- Host cell proteases: Critical determinants of coronavirus tropism and pathogenesisVirus Research, 2015
- Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndromeEuropean Journal of Immunology, 2014
- Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune systemMicrobes and Infection, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Autoantibodies in patients with Down Syndrome: Early senescence of the immune system or precocious markers for immunological diseases?Journal of Paediatrics and Child Health, 2007
- Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patientsBrazilian Journal of Medical and Biological Research, 2006